article_metadata: S Lena Kang-Birken Dena El-Sayed John Prichard
article_metadata: 10.1177/2325958218821653
article_metadata: J Int Assoc Provid AIDS Care
article_metadata: 2019 Jan-Dec;18:2325958218821653.
article_metadata: hiv/aids calcium elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide mutation emergence resistance
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/30798679/
article_metadata: Anti-HIV Agents / adverse effects Calcium / adverse effects Drug Interactions HIV Infections / virology Virus Activation
article_metadata: Anti-HIV Agents / adverse effects Calcium / adverse effects Drug Interactions HIV Infections / virology Virus Activation Case Reports Adult Calcium Carbonate / adverse effects Cobicistat / therapeutic use Drug Resistance, Viral Emtricitabine / therapeutic use Female HIV Infections / complications HIV Infections / drug therapy HIV-1 / drug effects HIV-1 / genetics Humans Leucovorin / adverse effects Quinolones / therapeutic use Tenofovir / therapeutic use Toxoplasmosis, Cerebral / complications Viral Load Anti-HIV Agents Quinolones elvitegravir Tenofovir Emtricitabine Calcium Carbonate Cobicistat Leucovorin Calcium
article_metadata: PMC6748456
article_metadata: 30798679
article_metadata: HIV Viral Rebound Due to a Possible Drug-Drug Interaction between Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Calcium-Containing Products: Report of 2 Cases
article_metadata: 2019